Search results
Results From The WOW.Com Content Network
Valneva along with Dynavax Technologies [11] developed a candidate inactivated whole virus vaccine against COVID-19, VLA2001, [12] derived from its Ixiaro Japanese encephalitis vaccine, which underwent a Phase 1/2 trial in the United Kingdom.
By Geoffrey Smith. For premium support please call: 800-290-4726 more ways to reach us
(Reuters) -Swiss drugmaker Novartis said on Saturday it had received a binding offer from Germany's Siemens Healthineers to acquire its molecular imaging business for Fluorine-18 positron emission ...
Novartis agreed to acquire U.S. radiopharmaceutical company Mariana Oncology for $1 billion upfront, boosting its portfolio of precision cancer treatments in development, the Swiss drug ...
Chinese Commercial News (菲律賓商報) Philippine Chinese Daily (菲律賓華報) Sino-Fil Daily (菲華日報) Ta Kung Pao - Philippine edition (大公報 - 菲律賓版) United Daily News (聯合日報) Wen Wei Po - Philippine edition (文匯報 - 菲律賓版) World News (世界日報)
Please help update this article to reflect recent events or newly available information. ( January 2022 ) This article attempts to document the timeline of the COVID-19 pandemic in the Philippines in 2022.
(Reuters) -Novartis failed to convince a federal court to block generic drugmaker MSN Pharmaceuticals from launching its own version of Novartis' blockbuster heart-failure drug Entresto, according ...
President Duterte during a meeting with members of the IATF-EID at the Matina Enclaves in Davao City in June 2020. The COVID-19 Immunization Program Management Organizational Structure was formed on October 26, 2020, to facilitate the distribution of COVID-19 vaccines in the Philippines, however this was replaced by a vaccine cluster within the Inter-Agency Task Force for the Management of ...